In a recent interview, Matt Covington, M.D., discussed challenges with the development of radioligand therapies for breast cancer and the potential of emerging radioligand agents to augment current treatment options in this patient population.
In a recent interview, Matt Covington, M.D., discussed challenges with the development of radioligand therapies for breast cancer and the potential of emerging radioligand agents to augment current treatment options in this patient population.